Scope
Description
Procurement of Revcovi, an approved enzyme replacement therapy (ERT) indicated for the treatment of adenosine deaminase severe combined immune deficiency.
Contract 1. Revcovi infusion
Supplier
Contract value
- £3,996,000 excluding VAT
- £4,795,200 including VAT
Above the relevant threshold
Award decision date
3 September 2025
Standstill period
- End: 12 September 2025
- 8 working days
Earliest date the contract will be signed
15 September 2025
Contract dates (estimated)
- 15 September 2025 to 14 September 2028
- 3 years
Main procurement category
Goods
CPV classifications
- 33600000 - Pharmaceutical products
Contract locations
- UKN - Northern Ireland
Procedure
Procedure type
Direct award
Supplier
CHIESI LIMITED
- Companies House: 02140985
- Public Procurement Organisation Number: PDRG-6355-YCVG
333 Styal Road
Manchester
M22 5LG
United Kingdom
Email: CustomerServices.UK@chiesi.com
Website: https://www.chiesi.uk.com/
Region: UKD33 - Manchester
Small or medium-sized enterprise (SME): No
Voluntary, community or social enterprise (VCSE): No
Supported employment provider: No
Public service mutual: No
Contract 1. Revcovi infusion
Contracting authority
Southern Health and Social Care Trust
- Public Procurement Organisation Number: PJCC-1957-RCGP
Craigavon Area Hospital, 68 Lurgan Road
Portadown
BT63 5QQ
United Kingdom
Email: dac@southerntrust.hscni.net
Region: UKN07 - Armagh City, Banbridge and Craigavon
Organisation type: Public authority - central government
Devolved regulations that apply: Northern Ireland